Patents by Inventor Anikó GÖBLYÖS

Anikó GÖBLYÖS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A3 adenosine receptor allosteric modulators
    Patent number: 9326978
    Abstract: The claimed subject matter relates to allosteric modulation of A3 adenosine receptor (A3AR) and provides for the use of an A3 adenosine receptor modulator (A3RM), for the preparation of pharmaceutical compositions for modulating the A3AR in a subject, as well as pharmaceutical compositions including the same and therapeutic methods including administering to a subject an amount of an A3RM, the amount being effective to modulate A3AR activity. The A3RM according to claimed subject matter are 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives. Also provided are 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: May 3, 2016
    Assignees: The United States of America, Represented by the Secretary, Dept. of Health and Human Services, Universiteit Leiden
    Inventors: Anikó Göblyös, Johannes Brussee, Adriaan P. Ijzerman, Zhan-Guo Gao, Kenneth Jacobson
  • A3 ADENOSINE RECEPTOR ALLOSTERIC MODULATORS
    Publication number: 20130197025
    Abstract: The claimed subject matter relates to allosteric modulation of A3 adenosine receptor (A3AR) and provides for the use of an A3 adenosine receptor modulator (A3RM), for the preparation of pharmaceutical compositions for modulating the A3AR in a subject, as well as pharmaceutical compositions including the same and therapeutic methods including administering to a subject an amount of an A3RM, the amount being effective to modulate A3AR activity. The A3RM according to claimed subject matter are 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives. Also provided are 1H-Imidazo-[4,5-c]quinolin-4-amine derivatives.
    Type: Application
    Filed: March 13, 2013
    Publication date: August 1, 2013
    Applicants: Universiteit Leiden, The Government Of The United State Of America, Represented By The Secretary, Dept. Of Health and
    Inventors: Anikó GÖBLYÖS, Johannes BRUSSEE, Adriaan P. IJZERMAN, Zhan-Guo GAO, Kenneth JACOBSON